Creon 114000 [USP'U]/1 (Pancrelipase CAPSULE, DELAYED RELEASE PELLETS) 114000 [USP'U]/1

Creon 114000 [USP'U]/1 is a delayed-release pancreatic enzyme supplement designed to aid digestion. It contains pancrelipase, which helps break down fats, proteins, and carbohydrates. This medication is commonly used for conditions like exocrine pancreatic insufficiency.

Strength

114000 [USP'U]/1

Pack Size

1 BOTTLE in 1 CARTON (0032-3016-12) / 12 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE

Manufacturer / TM Owner

AbbVie Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Creon 114000 [USP'U]/1 is primarily used to manage digestive issues related to exocrine pancreatic insufficiency. This condition occurs when the pancreas does not produce enough enzymes to digest food properly. The medication helps break down fats, proteins, and carbohydrates, making it easier for the body to absorb nutrients. It is often prescribed for individuals who have had their pancreas removed or have chronic pancreatitis.

Side Effects

Common effects of Creon 114000 [USP'U]/1 may include improved digestion and reduced symptoms like bloating, gas, and diarrhea. Some users might experience mild stomach discomfort or changes in bowel movements. These effects vary and are not experienced by everyone.

Precautions & Warnings

Creon 114000 [USP'U]/1 should be taken as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions. Keep the medication out of reach of children and store it at room temperature. Always consult a healthcare professional before starting any new medication.

Avoid Interactions

Creon 114000 [USP'U]/1 may interact with certain medications, including antacids and other digestive enzymes. It is important to inform your healthcare provider about all medications you are taking. Alcohol and certain foods may also affect the effectiveness of the medication.

Frequently Asked Questions

Creon 114000 [USP'U]/1 is used to aid digestion in individuals with exocrine pancreatic insufficiency, helping to break down fats, proteins, and carbohydrates.

Creon 114000 [USP'U]/1 should be taken orally with meals or snacks, as directed by a healthcare provider.

Common side effects may include mild stomach discomfort, bloating, gas, and changes in bowel movements.

It is important to consult a healthcare provider before taking Creon 114000 [USP'U]/1 with other medications, as interactions may occur.

Creon 114000 [USP'U]/1 should be stored at room temperature, away from moisture and heat, and out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.